Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes

Journal of Experimental Medicine

Volumn 188, Issue 10, 1998, Pages 1831-1839

  Lehuen, Agnès ^a   Lantz, Olivier ^a   Beaudoin, Lucie ^a   Laloux, Véronique ^a   Carnaud, Claude ^a   Bendelac, Albert ^b   Bach, Jean François ^a   Monteiro, Renato C ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b PRINCETON UNIVERSITY   (United States)

Author keywords

Interleukin 4; Natural killer T cells; Nonobese diabetic; Transgenic mice; Type 1 diabetes

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR;

ADOLESCENT; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE RESISTANCE; FEMALE; IMMUNOGLOBULIN PRODUCTION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; CYTOKINES; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN E; INTERLEUKIN-4; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; SPLEEN; T-LYMPHOCYTE SUBSETS; TH2 CELLS;

EID: 0032538904     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.10.1831     Document Type: Article

References (37)

1. Bach, J.F. 1994. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 15:516-542.
2. + T cells. J. Exp. Med. 166:823-832.
3. Rapoport, M.J., A. Jaramillo, D. Zipris, A.H. Lazarus, D.V. Serreze, E.H. Leiter, P. Cyopick, J.S. Danska, and T.L. Delovitch. 1993. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178:87-99.
4. Cameron, M.J., G.A. Arreaza, P. Zucker, S.W. Chensue, R.M. Stricter, S. Chakrabarti, and T.L. Delovitch. 1997. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. J. Immunol. 159:4686-4692.
5. Debray-Sachs, M., C. Carnaud, C. Boitard, H. Cohen, I. Gresser, P. Bedossa, and J.F. Bach. 1991. Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J. Autoimmun. 4:237-248.
6. Trembleau, S., G. Penna, E. Bosi, A. Mortara, M.K. Gately, and L. Adorini. 1995. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181:817-821.
7. Haskins, K., and M. McDuffie. 1990. Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science. 249:1433-1436.
8. Katz, J.D., C. Benoist, and D. Mathis. 1995. T helper cell subsets in insulin-dependent diabetes. Science. 268:1185-1188.
9. + Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J. Clin. Invest. 95:2979-2985.
10. Shehadeh, N.N., F. La Rosa, and K.J. Lafferty. 1993. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmun. 6:291-300.
11. Fox, C.J., and J.S. Danska. 1997. IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in non-obese diabetic mice. J. Immunol. 158:2414-2424.
12. Gombert, J.M., A. Herbelin, E. Tancrede-Bohin, M. Dy, C. Carnaud, and J.F. Bach. 1996. Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur. J. Immunol. 26:2989-2998.
13. Wilson, S.B., S.C. Kent, K.T. Patton, T. Orban, R.A. Jackson, M. Exley, S. Porcelli, D.A. Schatz, M.A. Atkinson, S.P. Balk, et al. 1998. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature. 391:177-181.
14. - T cells in mice and humans. J. Exp. Med. 180:1097-1106.
15. Bendelac, A., O. Lantz, M.E. Quimby, J.W. Yewdell, J.R. Bennink, and R.R. Brutkiewicz. 1995. CD1 recognition by mouse NK1 + T lymphocytes. Science. 268:863-865.
16. Bendelac, A., M.N. Rivera, S.H. Park, and J.H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535-562.
17. - α/β T cells demonstrates preferential use of several Vβ genes and an invariant TCR α chain. J. Exp. Med. 178:1-16.
18. Lanier, L.L., C. Chang, and J.H. Phillips. 1994. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J. Immunol. 153:2417-2428.
19. - T cells. J. Exp. Med. 186:109-120.
20. Yoshimoto, T., A. Bendelac, C. Watson, J. Hu-Li, and W.E. Paul. 1995. Role of NK1.1+ T cells in a TH2 response and in immunoglobulin E production. Science. 270:1845-1847.
21. Yoshimoto, T., A. Bendelac, J. Hu-Li, and W.E. Paul. 1995. Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4. Proc. Natl. Acad. Sci. USA. 92:11931-11934.
22. Bendelac, A., R.D. Hunziker, and O. Lantz. 1996. Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells. J. Exp. Med. 184: 1285-1293.
23. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/ Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 187:1047-1056.
24. Bendelac, A., C. Boitard, J.F. Bach, and C. Carnaud. 1989. Neonatal induction of allogeneic tolerance prevents T cell-mediated autoimmunity in NOD mice. Eur. J. Immunol. 19:611-616.
25. Hu-Li, J., J. Ohara, C. Watson, W. Tsang, and W.E. Paul. 1989. Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J. Immunol. 142:800-807.
26. Ohara, J., and W.E. Paul. 1985. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature. 315:333-336.
27. + T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179:1285-1295.
28. von Boehmer, H., J. Kirberg, and B. Rocha. 1991. An unusual lineage of α/β T cells that contains autoreactive cells. J. Exp. Med. 174:1001-1008.
29. Curnow, S.J., C. Boyer, M. Buferne, and A.M. Schmitt-Verhulst. 1995. TCR-associated ζ-Fc∈RIγ heterodimers on CD4-CD8-NK1.1+ T cells selected by specific class 1 MHC antigen. Immunity. 3:427-438.
30. Mieza, M.A., T. Itoh, J.Q. Cui, Y. Makino, T. Kawano, K. Tsuchida, T. Koike, T. Shirai, H. Yagita, A. Matsuzawa, et al. 1996. Selective reduction of Vα14 NK T cells associated with disease development in autoimmune-prone mice. J. Immunol. 156:4035-4040.
31. + cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms. J. Exp. Med. 177:155-164.
32. Levine, S., and R. Sowinski. 1973. Experimental allergic encephalomyelitis in inbred and outbred mice. J. Immunol. 110: 139-143.
33. Trembleau, S., G. Penna, S. Gregori, M.K. Gately, and L. Adorini. 1997. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes. Eur. J. Immunol. 27:2330-2339.
34. Mueller, R., T. Krahl, and N. Sarvetnick. 1996. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 184:1093-1099.
35. Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991-1045.
36. Janeway, C.A. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp. Quant. Biol. 54:1-13.
37. Fearon, D.T., and R.M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science. 272:50-54.